Cerebrolysin — Indexed Studies

[The effect of Cerebrolysin on the development of skills in patients after acute cerebrovascular accidents].

Shmonin AA, Kashaev IK, Luchinin EA et al.

[Experience of using of Cerebrolysin in comprehensive rehabilitation of a patient after ischemic stroke with motor deficit and aphasia].

Khatkova SE, Pavlyuchenkova OS, Golovanova AV et al.

Surgical excision of cerebral glioma and multimodal treatment including Cerebrolysin: a case report.

González JDSR, Tapia A

Safety and feasibility of cerebrolysin in treatment of primary intracerebral hemorrhage (CLINCH)-a prospective, randomized, open-label, blinded endpoint pilot trial.

Kobayashi A, Rutkowska K, Gocyla-Dudar K et al.

Evaluating the Effect of Cerebrolysin as an Adjuvant to Standard Therapy in Patients with Acute Ischemic Stroke: A Prospective Observational Study.

Kandasamy G, Arumugam V, Orayj K et al.

[A clinical case of treating a patient with severe ischemic stroke and cancer].

Marchenko SV, Hil IH, Hil UV et al.

[Cerebrolysin with reperfusion therapy in ischemic stroke: a prospective analysis of multimodal brain imaging data from the CEREHETIS trial].

Kalinin MN, Khasanova DR

Effect of Cerebrolysin on Cognitive Function and Delirium in Coronary Artery Bypass Graft Patients.

Stadnik A, Jezierska M, Płotek W et al.

Efficacy of Cerebrolysin Treatment as an Add-On Therapy to Mechanical Thrombectomy in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion in Anterior Circulation: Results of a 3-Month Follow-up of a Prospective, Open Label, Single-Center Study.

Staszewski J, Dębiec A, Strilciuc S et al.

[Cerebrolysin and the optimal timing of anticoagulation resumption in stroke: combined post hoc survival analysis of the CEREHETIS trial].

Kalinin MN, Khasanova DR

[Effect of neurofeedback training on relative α variant score monitored by bedside continuous electroencephalography and optic nerve sheath diameter evaluated by ultrasound in patients with ischemic hypoxic encephalopathy].

Sun J, Wan J

Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study.

Homberg V, Jianu DC, Stan A et al.

Cerebrolysin in Patients Diagnosed with Subarachnoid Hemorrhage-The Results of an Observational Cohort Study.

Kojder K, Jarosz K, Andrzejewska A et al.

Efficacy analysis of neuroprotective drugs in patients with acute ischemic stroke based on network meta-analysis.

Li M, Huo X, Chang Q et al.

[Cerebrolysin in the preventive therapy of dementia in elderly patients with mild cognitive impairment: a three-year prospective comparative study].

Ponomareva EV, Androsova LV, Krynskiy SA et al.

Cerebrolysin Concentrate: Therapeutic Potential for Severe Oral Apraxia After Stroke: A Case Report.

Jeon H, Kim DY

Add-on treatment with Cerebrolysin improves clinical symptoms in patients with ALS: results from a prospective, single-center, placebo-controlled, randomized, double-blind, phase II study.

Firstenfeld AJ, Listorti J, Jalaff N et al.

[Cerebrolysin as an early add-on to reperfusion therapy: heterogeneous treatment effect analysis in ischemic stroke patients with varying risk of hemorrhagic transformation].

Kalinin MN, Khasanova DR

The Effects of Neuromonitoring and Cerebrolysin Administration on Outcomes in Patients with Traumatic Brain Injury-An Interventional Pilot Study.

Jarosz K, Kojder K, Skonieczna-Żydecka K et al.

EFFECT OF INVESTIGATIONAL COMBINATIONS OF NEUROPROTECTANTS ON THE LEVEL OF S 100 AND NSE PROTEIN IN THE BLOOD SERUM OF PATIENTS WITH MODERATE AND SEVERE ISCHEMIC STROKE.

Karimulin R, Semenenko A

The effectiveness of cerebrolysin, a multi-modal neurotrophic factor, for treatment of post-covid-19 persistent olfactory, gustatory and trigeminal chemosensory dysfunctions: a randomized clinical trial.

Hamed SA, Ahmed MAA

A retrospective study of Cerebrolysin in patients with moderate to severe traumatic brain injury: Cognitive and functional outcomes.

Soto C, Salinas P, Muñoz D et al.

Cerebrolysin in Patients with Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis.

Kojder K, Jarosz K, Bosiacki M et al.

[Effects of simultaneous use of Cerebrolysin and alteplase on hemorrhagic transformation of brain infarction and functional outcome in stroke patients: CEREHETIS, a randomized, multicenter pilot trial].

Khasanova DR, Kalinin MN

[Cerebrolysin Treatment Reduces the Risk of Mild Cognitive Decline to Dementia in 1st-Degree Relatives of Alzheimer's Patients: A Prospective Comparative Study].

Selezneva ND, Gavrilova SI

Noninvasive monitoring in a patient with SAH diagnosis treated with Cerebrolysin - case report and review of the literature.

Kojder K, Jarosz K, Andrzejewska A et al.

Cerebrolysin and repetitive transcranial magnetic stimulation (rTMS) in patients with traumatic brain injury: a three-arm randomized trial.

Verisezan Rosu O, Jemna N, Hapca E et al.

Cerebrolysin in Patients with TBI: Systematic Review and Meta-Analysis.

Jarosz K, Kojder K, Andrzejewska A et al.

Cerebrolysin as an Early Add-on to Reperfusion Therapy: Risk of Hemorrhagic Transformation after Ischemic Stroke (CEREHETIS), a prospective, randomized, multicenter pilot study.

Khasanova DR, Kalinin MN

Extended Poststroke Rehabilitation Combined with Cerebrolysin Promotes Upper Limb Motor Recovery in Early Subacute Phase of Rehabilitation: A Randomized Clinical Study.

Mitrović SZ, Konstantinović LM, Miler Jerković V et al.

Prospective Randomized Control Trial to Compare the Role of Injection Cerebrolysin for 10 Days Duration Against Placebo in Operated Cases of Degenerative Cervical Myelopathy.

Sharma A, Agrawal H, Naseem A et al.

A novel pharmacological treatment concept for neuroprotection in severe traumatic brain injury-Two case reports.

Trimmel H, Herzer G, Derdak C et al.

Cerebrolysin Use in Patients with Liver Damage-A Translational Study.

Morega S, Gresita A, Mitran SI et al.

Modulation of Amyloid-β and Tau in Alzheimer's Disease Plasma Neuronal-Derived Extracellular Vesicles by Cerebrolysin® and Donepezil.

Alvarez XA, Winston CN, Barlow JW et al.

Efficacy of Cerebrolysin Treatment as an Add-On Therapy to Mechanical Thrombectomy in Patients With Acute Ischemic Stroke Due to Large Vessel Occlusion: Study Protocol for a Prospective, Open Label, Single-Center Study With 12 Months of Follow-Up.

Staszewski J, Stȩpień A, Piusińska-Macoch R et al.

The Effect of Cerebrolysin on Anxiety, Depression, and Cognition in Moderate and Severe Traumatic Brain Injury Patients: A CAPTAIN II Retrospective Trial Analysis.

Mureșanu IA, Grad DA, Mureșanu DF et al.

Prospective Randomized Control Pilot Study to Compare the Role of Injection Cerebrolysin in Operated cases of Degenerative Cervical Myelopathy.

Sharma A, Marathe N, Aggarwal R et al.

Use of Cerebrolysin in combination with high-dose aspirin antithrombotic treatment of ischemic stroke: A case report.

Borisevich A, Veremeyuk K

Role of Cerebrolysin® in Rehabilitation in Ischemic Stroke: A Case Report.

Chanubol R, Lertbutsayanukul P

Clinical Efficacy of Cerebrolysin and Cerebrolysin plus Nootropics in the Treatment of Patients with Acute Ischemic Stroke in Vietnam.

Tran L, Alvarez XA, Le HA et al.

Efficacy and safety of Cerebrolysin after futile recanalisation therapy in patients with severe stroke.

Poljakovic Z, Supe S, Ljevak J et al.

Cerebrolysin Combined with Rehabilitation Enhances Motor Recovery and Prevents Neural Network Degeneration in Ischemic Stroke Patients with Severe Motor Deficits.

Chang WH, Lee J, Shin YI et al.

Effect of cerebrolysin on neurodevelopmental outcome of high risk preterm infants: A randomized controlled trial.

Samir A, Nasef N, Fathy K et al.

Intra-arterial infusion of autologous bone marrow mononuclear cells combined with intravenous injection of cerebrolysin in the treatment of middle cerebral artery ischemic stroke: Case report.

Le VC, Nguyen NH, Le SH

Using low-dose tissue plasminogen activator through external ventricular drain and Cerebrolysin for the treatment of severe intraventricular hemorrhage: A case report.

Hoang Ngoc N, Van Tuyen N

[Delayed effects of cerebrolysin in the prevention of cognitive impairment progression in the first degree relatives of patients with Alzheimer's disease: the role of the ApoE genotype].

Selezneva ND, Gavrilova SI, Kolykhalov IV

Randomized, placebo-controlled, double-blind, pilot trial to investigate safety and efficacy of Cerebrolysin in patients with aneurysmal subarachnoid hemorrhage.

Woo PYM, Ho JWK, Ko NMW et al.

The Effect of Cerebrolysin on the Predictive Value of Baseline Prognostic Risk Score in Moderate and Severe Traumatic Brain Injury.

Birle C, Slavoaca D, Muresanu I et al.

[Choice of neuroprotective therapy regimens in patients with chronic cerebral ischemia, taking into account the synergy of drug interactions].

Gromova OA, Torshin IY, Putilina MV et al.

Serum VEGF Predicts Clinical Improvement Induced by Cerebrolysin Plus Donepezil in Patients With Advanced Alzheimer's Disease.

Alvarez XA, Alvarez I, Martinez A et al.

[Cognitive rehabilitation of patients with neurodegenerative diseases].

Levin OS, Bogolepova AN

[Cognitive rehabilitation of patients with focal brain damage].

Bogolepova AN, Levin OS